BDBM243202 (2S)-1-((R)-2-(3-Fluoro-4-(5- (trifluoromethyl)-1,2,4-oxadiazol-3- yl)benzamido)propyl)-2- methylpyrrolidin-1-ium formate::US10053434, 23
SMILES: C[C@H](C[NH+]1CCC[C@@H]1C)NC(=O)c1ccc(-c2noc(n2)C(F)(F)F)c(F)c1
InChI Key: InChIKey=JXGNSCIUOHPCHU-MNOVXSKESA-O
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HDAC4 (Homo sapiens (Human)) | BDBM243202 ((2S)-1-((R)-2-(3-Fluoro-4-(5- (trifluoromethyl)-1,...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
CHDI FOUNDATION, INC. US Patent | Assay Description 5 μL of each solution of 1:20 diluted compound from above was transferred to a clear bottomed, black, 384-well assay plate using the Bravo or th... | US Patent US10053434 (2018) BindingDB Entry DOI: 10.7270/Q2MG7RJZ | |||||||||||
More data for this Ligand-Target Pair |